Burning Rock Biotech Limited
(BNR)Financial Statements · SEC EDGAR XBRL
Revenue
$77.2M
+9.2%
Net Income
-$7.9M
+83.3%
Gross Margin
74.7%
Op. Income
-$7.8M
+84.0%
FCF
-$4.8M
+64.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Pre-Tax Income
Income Tax Expense
Net Income
Shares Outstanding (Diluted)